RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,760.00
+150.00 (2.67%)
At close: May 29, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 49.92 billion as of June 1, 2026. Its market cap has increased by 3.97% in one year.
Market Cap
49.92B
Enterprise Value
49.44B
Revenue
137.35B
Ranking
n/a
PE Ratio
8.90
Stock Price
5,760.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 49.92B, a decrease of -65.14%. That is a compound annual growth rate of -24.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 49.92B | -22.16% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 69.76B |
| Hwail Pharmaceutical | 68.27B |
| Samik Pharmaceutical Company LTD. | 63.15B |
| Sinil Pharmaceutical | 61.66B |
| Jin Yang Pharmaceutical | 55.13B |
| BL Pharmtech | 50.88B |
| Korea Arlico Pharm | 43.84B |
| Eagle Veterinary Technology Co.,Ltd | 42.92B |